Literature DB >> 3408665

Erythropoietic protoporphyria exacerbated by oral iron therapy.

A Milligan1, R A Graham-Brown, I Sarkany, H Baker.   

Abstract

Four patients with erythropoietic protoporphyria (EPP) are reported, in whom oral iron produced clear-cut clinical and biochemical deterioration. This suggests that there are two biochemically and genetically distinct sub-groups of EPP patients distinguished by their dramatically different response to oral iron.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3408665     DOI: 10.1111/j.1365-2133.1988.tb07102.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  14 in total

1.  The diagnosis and management of erythropoietic protoporphyria.

Authors:  Manish Thapar; Herbert L Bonkovsky
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

Review 2.  Liver disease in erythropoietic protoporphyria: insights and implications for management.

Authors:  A V Anstey; R J Hift
Journal:  Postgrad Med J       Date:  2007-12       Impact factor: 2.401

Review 3.  Liver disease in erythropoietic protoporphyria: insights and implications for management.

Authors:  A V Anstey; R J Hift
Journal:  Gut       Date:  2007-03-14       Impact factor: 23.059

4.  Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.

Authors:  Jasmin Barman-Aksoezen; Domenico Girelli; Caterina Aurizi; Xiaoye Schneider-Yin; Natascia Campostrini; Luca Barbieri; Elisabeth I Minder; Gianfranco Biolcati
Journal:  J Inherit Metab Dis       Date:  2017-02-09       Impact factor: 4.982

Review 5.  Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.

Authors:  Makiko Yasuda; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2019-01-18       Impact factor: 4.797

6.  Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases.

Authors:  Wided Najahi-Missaoui; Harry A Dailey
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

Review 7.  Liver disease and erythropoietic protoporphyria: a concise review.

Authors:  María José Casanova-González; María Trapero-Marugán; E Anthony Jones; Ricardo Moreno-Otero
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

Review 8.  Clinically important features of porphyrin and heme metabolism and the porphyrias.

Authors:  Siddesh Besur; Wehong Hou; Paul Schmeltzer; Herbert L Bonkovsky
Journal:  Metabolites       Date:  2014-11-03

Review 9.  Advances in the management of erythropoietic protoporphyria - role of afamelanotide.

Authors:  Ashley M Lane; Jerome T McKay; Herbert L Bonkovsky
Journal:  Appl Clin Genet       Date:  2016-12-12

10.  Clinical and biochemical improvement following low-dose intravenous iron therapy in a patient with erythropoietic protoporphyria.

Authors:  Douglas P Bentley; Elizabeth M Meek
Journal:  Br J Haematol       Date:  2013-07-29       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.